|
|
Volumn 304, Issue 6, 2010, Pages 624-626
|
|
Targeted therapies take aim against lung cancer and melanoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
CANCER VACCINE;
CARBOPLATIN;
CETUXIMAB;
CRIZOTINIB;
ENZYME INHIBITOR;
FLUOROURACIL;
FOLINIC ACID;
GLYCOPROTEIN GP 100;
IPILIMUMAB;
MELANOMA ANTIGEN;
OXALIPLATIN;
PACLITAXEL;
UNCLASSIFIED DRUG;
CANCER CHEMOTHERAPY;
CANCER RESEARCH;
CLINICAL TRIAL;
DRUG RESEARCH;
ENZYME INHIBITION;
HUMAN;
INOPERABLE CANCER;
LUNG NON SMALL CELL CANCER;
MELANOMA;
PRIORITY JOURNAL;
SHORT SURVEY;
|
|
EID: 77955349286
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2010.1055 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
